IDI Aloxidil 2% Minoxidil Cutaneous Solution 60ml
- Brand: IDI FARMACEUTICI Srl
- Product Code: 027261015
- EAN:
- Availability: In Stock (evaso in 24 ore)
- 3 items
for 21,07€ each - 4 items
for 20,64€ each - 5 items
for 20,21€ each
IDI Aloxidil 2% Minoxidil Cutaneous Solution
Aloxidil what it is for
It is a cutaneous solution useful for the treatment of alopecia.
Composition
100 ml of cutaneous solution contain: Active ingredient: Minoxidil g 2.00
Excipients
Ethyl alcohol g 51.40 Propylene glycol g 20.72 Purified water qs 100 ml
Therapeutic indications
ALOXIDIL 2% cutaneous solution is indicated for the symptomatic treatment of androgenic alopecia. The efficacy of ALOXIDIL 2% cutaneous solution in the following forms has not been established: localized or generalized congenital alopecia; cicatricial alopecia of various kinds (post-traumatic, psychic or infectious origin); acute alopecia diffused by toxic substances, by medicaments in which the regrowth of hair is conditioned by the suppression of the specific cause; area celsi. Furthermore, the tolerability and efficacy of ALOXIDIL 2% cutaneous solution in patients under the age of 18 and in patients over the age of 55 have not been established.
Contraindications
ALOXIDIL 2% cutaneous solution is contraindicated in patients with a history of hypersensitivity to minoxidil, propylene glycol or ethanol. ALOXIDIL 2% cutaneous solution should not be used in the presence of coronary heart disease, arrhythmias, congestive heart failure or valvulopathies. In the face of other cardiovascular disorders, the use of ALOXIDIL 2% cutaneous solution is subject to the judgment of the doctor. Patients with hypertension, including those being treated for this condition, should be closely monitored.
Dosage
FOR EXTERNAL USE ONLY. ALOXIDIL 2% cutaneous solution should only be used on the scalp and nowhere else on the body. The dosage is 1 ml, twice a day, applied to the areas affected by baldness, starting from the center. The dose is independent of the surface of the area to be treated. The daily dosage should not exceed 2 ml. The application relates to the device for the application itself in the following ways: Using the dropper: Fill the dropper up to the 1 ml mark. Then apply a few drops of ALOXIDIL 2% cutaneous solution on the scalp distributing the liquid by rubbing with the fingertips on the entire area affected by baldness. Repeat until all the dose contained in the dropper has been applied. Close the bottle carefully. After applying ALOXIDIL 2% cutaneous solution, wash your hands by rinsing thoroughly with water. Apply ALOXIDIL 2% cutaneous solution only on completely dry hair and scalp. Do not apply ALOXIDIL 2% cutaneous solution to other areas of the body. Do not use hair dryers to facilitate the drying of ALOXIDIL 2% cutaneous solution since this system could decrease the effect of the product. Clinical experience with ALOXIDIL 2% cutaneous solution indicates that bi-daily applications lasting 3–4 months may be required before there are obvious signs of hair growth. The onset of these signs and their intensity vary from patient to patient. In all cases, the doctor will have to evaluate the opportunity to suspend the treatment if no therapeutic result is observed within this period. Relapse to the pretreatment state following discontinuation of therapy occurs within 3–4 months.
Warnings and Precautions
Although the following effects have not been associated with the topical use of ALOXIDIL 2% cutaneous solution, some absorption of minoxidil through the scalp occurs with the use of the drug (mean value: 1.4%) and there is a risk potential for systemic effects such as: tachycardia, angina, edema or increased orthostatic hypotension induced by guanethidine. Patients should be monitored periodically for any suspicion of systemic effects caused by minoxidil. In carcinogenicity experiments performed in rats and mice, there have been reports of mammary tumors in female mice and tumors of the adrenal glands and foreskin in male rats. However, there is no evidence that these results predict a similar risk for humans. In the event of systemic side effects or dermatological reactions, discontinue administration of the drug and consult your doctor. In case of accidental contact with sensitive surfaces (eyes, skin abrasions, mucous membranes) ALOXIDIL 2% cutaneous solution causes burning and irritation. Therefore the area should be washed with plenty of fresh water. Accidental ingestion of the solution could lead to serious side effects. KEEP THE DRUG - AS 'AS ALL DRUGS - OUT OF REACH OF CHILDREN. The effects of ALOXIDIL 2% cutaneous solution in patients suffering from concomitant dermatological diseases, or patients receiving topical corticosteroid therapy or other dermatological preparations are currently unknown. It is not yet fully understood whether an occlusive dressing can increase drug absorption.
Interactions
No interactions associated with the use of ALOXIDIL 2% cutaneous solution are currently known. Although it has not been clinically demonstrated, there is a possibility of orthostatic hypotension in patients receiving concomitant therapy with guanethidine.
Side effects
The most frequent side effects that occurred during clinical trials with ALOXIDIL 2% cutaneous solution were minor dermatological reactions. The most frequent side effect was local irritation, consisting of peeling, erythema, dermatitis, dry skin, hypertrichosis (in areas other than those treated with ALOXIDIL 2% skin solution), burning sensation and rash. Other side effects that occurred infrequently included: allergic reactions (sensitization, hives, generalized erythema and facial edema), dizziness, tingling, headache, weakness, neuritis, edema, eye irritation, taste disturbance, ear infections (particularly otitis externa ) and visual disturbances. Rarely occurring side effects included hair abnormalities, chest pains, blood pressure changes, heart rate changes, hepatitis and kidney stones.
Pregnancy and breastfeeding
The effects of ALOXIDIL 2% cutaneous solution used in pregnancy are not known. Systemically administered minoxidil is excreted in human milk. ALOXIDIL 2% cutaneous solution should not be used in pregnant or lactating women.
Format
Aloxidil is sold in a 60ml bottle